|
|||||
|
|
Structure‐Based Design of Selective Noncovalent CDK12 Inhibitors |
|
| Authors: | Dr Jeffrey W Johannes Christopher R Denz Nancy Su Allan Wu Anna C Impastato Dr Scott Mlynarski Jeffrey G Varnes D Bryan Prince Dr Justin Cidado Ning Gao Dr Malcolm Haddrick Natalie H Jones Shaobin Li Xiuwei Li Yang Liu Dr Toan B Nguyen Dr Nichole O'Connell Dr Emma Rivers Dr Daniel W Robbins Ronald Tomlinson Dr Tieguang Yao Xiahui Zhu Dr Andrew D Ferguson Dr Michelle L Lamb Dr John I Manchester Dr Sylvie Guichard |
| Affiliation: | 1. Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA, USA;2. Discovery Sciences, IMED Biotech Unit, AstraZeneca, Boston, MA, USA;3. Discovery Sciences, IMED Biotech Unit, AstraZeneca Pharmaceuticals LP, Macclesfield, UK;4. Pharmaron Beijing Co. Ltd., Beijing, P.R. China;5. Discovery Sciences, IMED Biotech Unit, AstraZeneca Pharmaceuticals LP, Cambridge, UK |
| Abstract: | |
| Keywords: | |